Ahead of the IPO shares of the company were trading at Rs 1,730 apiece in the grey market marking a premium of Rs 605 or 53.77%.
SEBI recently gave a go-ahead for IPOs to companies like Paytm, Nykaa, Fino Payments, Policybazaar, Adani Wilmar and Star Health & Allied Insurance
The issue looks priced in line with its listed peers. The long term prospects of the company tend to be impressive owing to huge under-penetration.
Shares of the company are quoting at Rs 405 apiece in the grey market marking a premium of Rs 230 or 131% over its issue price of Rs 175.
Ami Organics seems to have an upper hand over Vijaya Diagnostic in terms of listing expectations.
Market experts are of the opinion that as many as 9 companies could raise around Rs 12,500 crore.
In the grey market shares of Vijaya Diagnostic Centre is quoting at a premium of Rs 10 or 1.88% while Ami Organics is at a premium of Rs 60 or 9.83%
Unlike the mad rush witnessed in the past few months, the response for IPOs in August was subdued especially from retail investors who were selective.
If good IPOs tap the market with an attractive valuation, leaving something for investors, we will see some record-breaking subscriptions, say experts
The P/BV comes around 8.6x which makes the issue fully priced against the superlative performance leaving little to nothing for investors